Quick Answer
ImageneBio, Inc. reported Net Income Loss of -$45.35 million for the year ending 2025.
- ImageneBio, Inc. showed a decrease of -24.0% in Net Income Loss from 2024 to 2025.
- This data is from ImageneBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), ImageneBio, Inc.'s Net Income Loss has declined by 2.5%.
- Historical annual values: Fiscal year 2025: -$45.35 million | Fiscal year 2024: -$36.57 million | Fiscal year 2023: -$68.17 million | Fiscal year 2022: -$68.77 million | Fiscal year 2021: -$34.12 million | Fiscal year 2020: -$44.26 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: